InvestorsHub Logo
Followers 6
Posts 1400
Boards Moderated 0
Alias Born 08/24/2014

Re: wallstreetbuyer post# 42441

Saturday, 12/09/2017 10:56:42 PM

Saturday, December 09, 2017 10:56:42 PM

Post# of 48316
Oncosec has raised the cash needed to get them to Interim PISCES data mid-2018. If results are good the price will rise significantly, remaining warrants will probably be executed and Oncosec will bank a lot more money from those warrants (if all warrants are executed-around $26 million dollars according to the latest SEC filing). 2018 will be all about the data and/or partnering. A collaboration, licensing deal, or partnership for TNBC or multi-gene construct before PISCES data would be an added bonus to get the shares moving again......if that doesn't happen then it is all about the PISCES data in 2018. I really hope we see something extra to boot though. If PISCES data is good I would expect a partnership/licensing deal with Merck to be announced....maybe even a buyout. If any of these things unfold then I think there is no need to worry about further dilution at this point.